Quantum-Si Incorporated (Nasdaq: CAPA) is a life sciences semiconductor company that went public through a business combination with HighCape Capital Acquisition Corp, sponsored by HighCape Capital Management, with shares beginning to trade on Nasdaq in 2021. The company develops proprietary semiconductor chips for next-generation protein sequencing and operates within the life sciences technology sector, targeting the emerging field of proteomics. Quantum-Si filed an 8-K current report with the Securities and Exchange Commission on May 16, 2023, disclosing a material event as required under exchange reporting obligations. As a post-combination public company, CAPA continues to advance its sequencing platform in the competitive genomics and proteomics landscape. Sign up at SpacDesk for full filings, sponsor data, and analytics on Quantum-Si and the broader SPAC universe.